R E C O G N I S I N G G L O B A L E X C E L L E N C E

Winner
Exxon Mobil Corporation
5959 Las Colinas Boulevard
Irving, Texas
75039-2298
United States
www.exxonmobil.com
Energy Firm Of The Year
Exxon Mobil Corporation is a multinational oil and gas and is one of the largest publicly traded companies by market
capitalalisation in the world and is the second largest company in the world by revenue. With 37 oil refineries
in 21 countries constituting a combined daily refining capacity of 6.3 million barrels (1,000,000 m3), Exxon
Mobil is also the largest refiner in the world.
Exxon Mobil markets fuel and lubricants under three brands worldwide: Exxon, Esso, and Mobil. Customers in the
United States have come to respect and rely on Exxon-branded fuels, services and lubricants for their personal and
business needs, while customers around the world will be familiar with Esso. Mobil is marketed around the world and
is known for performance and innovation. Mobil is recognised for its advanced technology in fuels, lubricants and
services. It also owns hundreds of smaller subsidiaries such as Imperial Oil Limited (69.6% ownership) in Canada, and
SeaRiver Maritime, a petroleum shipping company.
Exxon Mobil is organized into a number of global operating divisions which are grouped into three categories – upstream,
downstream and chemical. Their upstream division consists of oil exploration, extraction, shipping and wholesales
operations, the downstream consists of marketing, refining and retail operations, while the chemical’s division
consists of ExxonMobil Chemical Company.
ExxonMobil also have a Global Services Company which covers ExxonMobil Information Technology, Global Real
Estate and Facilities, Global Procurement and Business Support Centre’s.
Corporate LiveWire has selected ExxonMobil as its winner of Energy Firm Of The Year. As societies advance, they will
continue to need energy to power homes, businesses, industry, transportation, electricity generation and other vital
services. As the market leader in natural gases and oil worldwide, Exxon remain the singular most important company
in the energy sector. In a highly competitive field, it is incredibly difficult for an oil firm to tap into new reserves of oil
to meet rising global demands, however Exxon have still managed to turn over impressive profit margins of £5.8 billion
in their first quarter of the year. Over the past year, Exxon struck a $3.2 billion deal with Russia’s Rosneft that will allow
the US company to drill for oil in the Arctic Ocean, while they also claim to be working on several new fields in order to
drive production up by between 1% and 2% a year over the next four years. We at Corporate LiveWire look forward to
seeing the progression of ExxonMobil and will continue to enjoy their products for the foreseeable future.
Winner
Pfizer, Inc.
235 East 42 St,
New York City,
New York,
10017, United States
www.pfizer.com
+1 212 733 2323
Pharmaceutical Firm Of The Year
fizer, Inc. is the world’s largest research based pharmaceutical company. They discover, develop, manufacture
and market leading prescriptions and are committed to applying their science and global resources to improve
health and well-being at every stage of life. Pfizer strive to provide access to safe, effective and affordable medicines
and related health care services to the people who need them.
Their portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional
products and many of the world’s best-known consumer products. Every day, Pfizer work across developed and emerging
markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.
Consistent with their responsibility as the world’s leading biopharmaceutical company, they also collaborate with health
care providers, governments and local communities to support and expand access to reliable, affordable health care
around the world. For more than 150 years, Pfizer has worked to make a difference in the world of medicine.
In 2009, Pfizer had the greatest number of blockbuster products with 14, which includes five which they inherited
through the acquisition of Wyeth following their $68 billion acquisition. In addition to marketing branded pharmaceuticals
Pfizer is involved in the manufacture and sale of generics. In the US it does this through its Greenstone subsidiary
which it acquired as part of the acquisition of Pharmacia. Pfizer also has a licensing deal in place with Aurobindo which
grants the former access to a variety of oral solid generic products.
Corporate LiveWire has selected Pfizer as its winner of Pharmaceutical Firm Of The Year 2012. This title comes following
their recent sale of their infant nutrition business including the S-26 Gold, SMA and Promil brands to Nestle, the
world’s biggest food group by sales, for a jackpot of £7.35 billion. This clever move will provide more money and time
to focus on sales growth of its newer drugs and forecast for Inlyta, known chemically as axitinib. The twice-a-day pill
for hard-to-treat kidney cancer was endorsed by the company in January and could make a major breakthrough in the
development of cancer treatment worldwide.
Last autumn Pfizer also announced that it had agreed to a 10-year lease of more than 180,000 square feet of research
space from MIT in Cambridge, Massachusetts, US. The space will house Pfizer’s Cardivascular, Metabolic and Endocrine
Disease Research Unit and its Neuroscience Research Unit – and Pfizer anticipate its completion by the end of
2013. We at Corporate LiveWire look forward to tracking the progress of Pfizer’s products and wish them all the best
with future successes.
16 / Global Awards 2012 / CorporateLiveWire CorporateLiveWire / Global Awards 2012 / 17
P